Thermo Fisher Scientific’s US- and EU-based steriles manufacturing and fill-finish sites are equipped with state-of-the art technology to support pharmaceutical and biotech companies in bringing their sterile products to market and to the patients who need them, safely and efficiently. PDS services, offered by select sites, are typically smaller clinical batches as compared to commercial scale.
Our expertise in aseptic processing, fill-finish operations, and lyophilization, combined with robust regulatory support and quality control, ensure the highest standards of product quality and compliance.
Download the sites and capabilities overview to learn more.